Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Vaia Florou; Andrew E Rosenberg; Eric Wieder; Krishna V Komanduri; Despina Kolonias; Mohamed Uduman; John C Castle; Jennifer S Buell; Jonathan C Trent; Breelyn A Wilky

doi:10.1186/s40425-019-0792-9

Back

Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Journal article

Open access

Peer reviewed

Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution

Vaia Florou, Andrew E Rosenberg, Eric Wieder, Krishna V Komanduri, Despina Kolonias, Mohamed Uduman, John C Castle, Jennifer S Buell, Jonathan C Trent and Breelyn A Wilky

Journal for immunotherapy of cancer, Vol.7(1), pp.285-285

2019-11-06

DOI: https://doi.org/10.1186/s40425-019-0792-9

PMCID: PMC6833228

PMID: 31694703

Abstract

Following publication of the original article [1], the authors have reported that the following sentence "While of the same IgG1 class as ipilimumab, preclinical data suggests this molecule may have enhanced activity against T regulatory cells".

Files and links (1)

url

https://doi.org/10.1186/s40425-019-0792-9View

Published (Version of record) Open

Metrics

41 Record Views

31 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.118 Soft Tissue, Bone & Nerve Cancers; 1.118.1928 Angiosarcoma
Web Of Science research areas: Immunology; Oncology
ESI research areas: Immunology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
Creators: Vaia Florou - Department of Medicine, Division of Oncology, Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL, 33136, USA. vaia.florou@hsc.utah.edu
Andrew E Rosenberg - Department of Medicine, Division of Oncology, Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL, 33136, USA
Eric Wieder - Department of Medicine, Division of Oncology, Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL, 33136, USA
Krishna V Komanduri - Department of Medicine, Division of Oncology, Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL, 33136, USA
Despina Kolonias - Department of Medicine, Division of Oncology, Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL, 33136, USA
Mohamed Uduman - Agenus Inc., 3 Forbes Road, Lexington, MA, 02421, USA
John C Castle - Agenus Inc., 3 Forbes Road, Lexington, MA, 02421, USA
Jennifer S Buell - Agenus Inc., 3 Forbes Road, Lexington, MA, 02421, USA
Jonathan C Trent - Department of Medicine, Division of Oncology, Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL, 33136, USA
Breelyn A Wilky - Department of Medicine, Division of Oncology, Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine, 1475 NW 12th Avenue, Miami, FL, 33136, USA
Publication Details: Journal for immunotherapy of cancer, Vol.7(1), pp.285-285
Academic Unit: Miller School of Medicine; UMMG Department of Pathology; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 31694703
PMCID: PMC6833228
Record Identifier: 991031599294202976